Want to see CANF full AI Analyst Report?
Can-Fite BioPharma (CANF) Q2 2026 Earnings Report
CANF Q2 2026 EPS Results
- Actual EPS
- -$1.24
- Consensus EPS
- -$0.33
- Beat/Miss
- Missed by -$0.91
- One Year Ago EPS
- -$2.80
CANF Q2 2026 Revenue Results
- Actual Revenue
- $203.40K
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -0.09%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 09/08/2026
- Time
- Before Open
- Conference Call
- Tuesday, September 8, 2026
CANF Upcoming Earnings
Can-Fite BioPharma's next earnings date is estimated for April 1, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CANF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 01, 2027 | 2026 (Q4) | -0.80- | -5.97 | ― | ― |
| Sep 08, 2026 | 2026 (Q2) | -0.33-1.24 | -2.8 | 55.67% (+1.56) | |
| Mar 26, 2026 | 2025 (Q4) | -0.14-5.97 | -3.8 | -57.27% (-2.17) | |
| Nov 21, 2025 | 2025 (Q3) | -2.80-0.55 | ― | ― | |
| Aug 28, 2025 | 2025 (Q2) | -2.20-2.80 | -6.59 | 57.58% (+3.80) | |
| May 22, 2025 | 2025 (Q1) | ―- | ― | ― | |
| Apr 14, 2025 | 2024 (Q4) | -2.00-2.80 | -6.99 | 60.00% (+4.20) | |
| Nov 29, 2024 | 2024 (Q3) | -0.27-0.27 | -0.27 | -1.89% (-0.01) | |
| Aug 29, 2024 | 2024 (Q2) | -2.20-6.59 | -6.99 | 5.72% (+0.40) | |
| May 30, 2024 | 2024 (Q1) | -0.41-0.41 | 0 | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
